This segment focuses on providing integrated solutions for the biopharmaceutical industry, covering the entire bioprocess value chain. Research and development activities include the continuous improvement of cell culture media, bioreactors, filtration systems, and single-use technologies. Key technologies include single-use bioreactors, tangential flow filtration, and chromatography systems. The segment supports the development and production of therapeutics across various therapeutic areas, including oncology, immunology, and rare diseases. Patient impact is realized through the efficient and reliable production of life-saving drugs. Sartorius Stedim Biotech holds a strong market position due to its comprehensive product portfolio, technological expertise, and global presence. Future opportunities lie in the expansion of single-use technologies, automation, and data analytics for bioprocess optimization. Regulatory aspects are crucial, with products adhering to stringent quality standards and compliance requirements. Partnerships with biopharmaceutical companies and technology providers are essential for driving innovation and market access.

This segment provides laboratory products and services for research and development in the biopharmaceutical and related industries. R&D efforts focus on developing innovative laboratory equipment, consumables, and services to support scientific research. Key technologies include analytical balances, pipettes, and laboratory filtration systems. The segment supports research in various therapeutic areas, including drug discovery, cell biology, and molecular biology. Patient impact is achieved through enabling scientific breakthroughs and accelerating the development of new therapies. Sartorius Stedim Biotech's market position is strengthened by its reputation for quality, reliability, and a broad product portfolio. Future opportunities include the integration of digital solutions and automation in laboratory workflows. Regulatory compliance is essential, with products meeting relevant quality standards. Partnerships with research institutions and pharmaceutical companies are key to driving innovation and market expansion.